Healthcare -
Biotechnology - NASDAQ - US
$ 63.75
-1.65 %
$ 3.5 B
Market Cap
-31.87
P/E
ACLX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ACLX - Arcellx, Inc.
279 M
LAST VALUE
53.52%
2 YEAR CAGR
86.18%
5 YEAR CAGR
0.00%
10 YEAR CAGR